• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测自体肾活检并发症的临床参数。

Clinical parameters predicting complications in native kidney biopsies.

作者信息

Peters Björn, Nasic Salmir, Segelmark Mårten

机构信息

Department of Nephrology, Skaraborg Hospital, Skövde, Sweden.

Department of Public Health and Clinical Medicine, Umeå University, Umea, Sweden.

出版信息

Clin Kidney J. 2019 Oct 19;13(4):654-659. doi: 10.1093/ckj/sfz132. eCollection 2020 Aug.

DOI:10.1093/ckj/sfz132
PMID:32905412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7467621/
Abstract

BACKGROUND

Renal biopsies are essential in nephrology but they are invasive and complications can occur. The aim of this study was to explore clinical parameters that can be used as predictors for biopsy complications.

METHODS

Clinical parameters such as demographics, biopsy indications, serology, comorbidities and clinical chemistry were retrieved from a regional biopsy registry between 2006 and 2015 and from a nationwide registry between 2015 and 2017. Clinical data before biopsy were compared with data on major biopsy complications. Fisher's exact and tests were used and odds ratios (ORs) with 95% confidence intervals (CIs) were presented. Univariate and multiple binary logistic regression analyses were performed with complications as outcome. A two-sided P-value <0.05 was considered significant.

RESULTS

In total, 2835 consecutive native kidney biopsies were analysed (39% women and 61% men, median age 57 years). No death and nephrectomy due to biopsy complications were registered. The frequency of major biopsy complications was 5.65%. In the multiple logistic regression, the risk for complications increased in women [OR 1.51 (95% CI 1.08-2.11)] and decreased with age: 45-64 years age group [OR 0.66 (95% CI 0.44-0.99)] and >74 years age group [OR 0.51 (95% CI 0.27-0.96)]. Among comorbidities, patients with diabetes mellitus type 2 [OR 2.07 (95% CI 1.15-3.72)] and non-ischaemic heart disease [OR 3.20 (95% CI 1.64-6.25)] had a higher risk for major biopsy complications.

CONCLUSIONS

Female gender, younger age (≤44 years), diabetes mellitus type 2 and non-ischaemic heart disease were found as risk factors for major biopsy complications.

摘要

背景

肾活检在肾脏病学中至关重要,但具有侵入性且可能发生并发症。本研究的目的是探索可作为活检并发症预测指标的临床参数。

方法

从2006年至2015年的地区活检登记处以及2015年至2017年的全国登记处获取人口统计学、活检指征、血清学、合并症和临床化学等临床参数。将活检前的临床数据与主要活检并发症的数据进行比较。使用Fisher精确检验和卡方检验,并给出比值比(OR)及其95%置信区间(CI)。以并发症为结局进行单因素和多因素二元逻辑回归分析。双侧P值<0.05被认为具有统计学意义。

结果

共分析了2835例连续的自体肾活检病例(女性占39%,男性占61%,中位年龄57岁)。未记录到因活检并发症导致的死亡和肾切除术。主要活检并发症的发生率为5.65%。在多因素逻辑回归中,女性并发症风险增加[OR 1.51(95%CI 1.08 - 2.11)],且随年龄增长而降低:45 - 64岁年龄组[OR 0.66(95%CI 0.44 - 0.99)]和>74岁年龄组[OR 0.51(95%CI 0.27 - 0.96)]。在合并症中,2型糖尿病患者[OR 2.07(95%CI 1.15 - 3.72)]和非缺血性心脏病患者[OR 3.20(95%CI 1.64 - 6.25)]发生主要活检并发症的风险更高。

结论

女性、较年轻年龄(≤44岁)、2型糖尿病和非缺血性心脏病被发现是主要活检并发症的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3ad/7467621/aca356d7f1c3/sfz132f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3ad/7467621/aca356d7f1c3/sfz132f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3ad/7467621/aca356d7f1c3/sfz132f1.jpg

相似文献

1
Clinical parameters predicting complications in native kidney biopsies.预测自体肾活检并发症的临床参数。
Clin Kidney J. 2019 Oct 19;13(4):654-659. doi: 10.1093/ckj/sfz132. eCollection 2020 Aug.
2
Risk factors for biopsy complications in initial versus subsequent biopsies in native and transplant kidneys.原发性和移植肾初次活检与再次活检中活检并发症的危险因素。
Acta Radiol. 2021 Oct;62(10):1426-1432. doi: 10.1177/0284185120966687. Epub 2020 Oct 23.
3
Desmopressin (Octostim®) before a native kidney biopsy can reduce the risk for biopsy complications in patients with impaired renal function: A pilot study.去氨加压素(奥曲肽)在进行自体肾活检前使用可降低肾功能受损患者的活检并发症风险:一项初步研究。
Nephrology (Carlton). 2018 Apr;23(4):366-370. doi: 10.1111/nep.13004.
4
Renal transplant biopsy complications: assessment of risk factors and potential of desmopressin to decrease risk of hemorrhage.肾移植活检并发症:危险因素评估及去氨加压素降低出血风险的潜力
Acta Radiol. 2020 Dec;61(12):1717-1723. doi: 10.1177/0284185120910590. Epub 2020 Mar 25.
5
Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy.经皮超声引导下肾活检出血并发症的预测因素
Kidney Int. 2004 Oct;66(4):1570-7. doi: 10.1111/j.1523-1755.2004.00922.x.
6
The risks associated with percutaneous native kidney biopsies: a prospective study.经皮肾活检的相关风险:一项前瞻性研究。
Nephrol Dial Transplant. 2023 Feb 28;38(3):655-663. doi: 10.1093/ndt/gfac177.
7
A study of clinical complications and risk factors in 1,001 native and transplant kidney biopsies in Sweden.瑞典1001例自体肾和移植肾活检的临床并发症及危险因素研究。
Acta Radiol. 2014 Sep;55(7):890-6. doi: 10.1177/0284185113506190. Epub 2013 Sep 25.
8
Complications and Risks of Percutaneous Renal Biopsy.经皮肾活检的并发症与风险
Open Access Maced J Med Sci. 2019 Mar 29;7(6):992-995. doi: 10.3889/oamjms.2019.226. eCollection 2019 Mar 30.
9
Increased risk of renal biopsy complications in patients with IgA-nephritis.IgA 肾病患者肾活检并发症风险增加。
Clin Exp Nephrol. 2015 Dec;19(6):1135-41. doi: 10.1007/s10157-015-1121-3. Epub 2015 May 8.
10
Sixteen Gauge biopsy needles are better and safer than 18 Gauge in native and transplant kidney biopsies.在自体肾活检和移植肾活检中,16号活检针比18号活检针更好且更安全。
Acta Radiol. 2017 Feb;58(2):240-248. doi: 10.1177/0284185116641349. Epub 2016 Jul 20.

引用本文的文献

1
The safety of percutaneous renal biopsy for acute kidney injury in metastatic renal cell cancer patients with reduced nephron mass.肾单位数量减少的转移性肾细胞癌患者经皮肾活检对急性肾损伤的安全性
Front Nephrol. 2025 Aug 6;5:1615779. doi: 10.3389/fneph.2025.1615779. eCollection 2025.
2
Longitudinal non-targeted metabolomic profiling of urine samples for monitoring of kidney transplantation patients.尿液样本的纵向非靶向代谢组学分析用于监测肾移植患者。
Ren Fail. 2024 Dec;46(1):2300736. doi: 10.1080/0886022X.2023.2300736. Epub 2024 Jan 12.
3
Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety.

本文引用的文献

1
Comparison of native and transplant kidney biopsies: diagnostic yield and complications.自体肾活检与移植肾活检的比较:诊断率及并发症
Clin Kidney J. 2018 Oct;11(5):616-622. doi: 10.1093/ckj/sfy051. Epub 2018 Jul 6.
2
Desmopressin (Octostim®) before a native kidney biopsy can reduce the risk for biopsy complications in patients with impaired renal function: A pilot study.去氨加压素(奥曲肽)在进行自体肾活检前使用可降低肾功能受损患者的活检并发症风险:一项初步研究。
Nephrology (Carlton). 2018 Apr;23(4):366-370. doi: 10.1111/nep.13004.
3
Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a "real-world" study.
肾脏疾病诊断中的肾活检:适应证、技术及安全性
J Clin Med. 2023 Oct 9;12(19):6424. doi: 10.3390/jcm12196424.
4
Causes of nephrotic syndrome in Sweden: The relevance of clinical presentation and demographics.瑞典肾病综合征的病因:临床表现和人口统计学的相关性。
Front Nephrol. 2023 Mar 17;3:1026864. doi: 10.3389/fneph.2023.1026864. eCollection 2023.
5
Safety of Obtaining an Extra Biobank Kidney Biopsy Core.获取额外的生物样本库肾脏活检组织芯的安全性。
J Clin Med. 2022 Mar 7;11(5):1459. doi: 10.3390/jcm11051459.
6
Biopsying Diabetics … How Risky Is It?对糖尿病患者进行活检……风险有多大?
Kidney Int Rep. 2021 Dec 31;7(2):149-151. doi: 10.1016/j.ekir.2021.12.026. eCollection 2022 Feb.
7
Coding practice in national and regional kidney biopsy registries.国家和地区肾活检登记处的编码实践。
BMC Nephrol. 2021 May 24;22(1):193. doi: 10.1186/s12882-021-02365-3.
8
Safety and utility of kidney biopsy in patients with estimated glomerular filtration rate < 30 ml/min/1.73 m.估计肾小球滤过率 < 30 ml/min/1.73 m 患者行肾活检的安全性和实用性。
Nephrology (Carlton). 2021 Aug;26(8):659-668. doi: 10.1111/nep.13879. Epub 2021 Apr 14.
9
Kidney biopsy in the elderly: diagnostic adequacy and yield.老年患者的肾脏活检:诊断充分性和检出率。
Int Urol Nephrol. 2021 Jan;53(1):105-109. doi: 10.1007/s11255-020-02640-6. Epub 2020 Sep 17.
糖尿病与接受传统抗凝治疗的肺栓塞患者出血增加有关:一项“真实世界”研究的结果
J Thromb Thrombolysis. 2017 May;43(4):540-549. doi: 10.1007/s11239-017-1473-5.
4
The Native Kidney Biopsy: Update and Evidence for Best Practice.自体肾活检:最新进展与最佳实践证据
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):354-62. doi: 10.2215/CJN.05750515. Epub 2015 Sep 2.
5
Renal biopsy in the elderly: a single-center experience.老年人肾活检:单中心经验
Int Urol Nephrol. 2015 Aug;47(8):1397-401. doi: 10.1007/s11255-015-1035-8. Epub 2015 Jul 2.
6
Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies.自体肾经皮肾穿刺活检:1055例活检的单中心经验
Am J Nephrol. 2014;39(2):153-62. doi: 10.1159/000358334. Epub 2014 Feb 11.
7
A study of clinical complications and risk factors in 1,001 native and transplant kidney biopsies in Sweden.瑞典1001例自体肾和移植肾活检的临床并发症及危险因素研究。
Acta Radiol. 2014 Sep;55(7):890-6. doi: 10.1177/0284185113506190. Epub 2013 Sep 25.
8
Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010.1988-2010 年挪威 715 例儿童和 8573 例成人经皮肾活检的安全性和并发症。
Clin J Am Soc Nephrol. 2012 Oct;7(10):1591-7. doi: 10.2215/CJN.02150212. Epub 2012 Jul 26.
9
Complications of the percutaneous kidney biopsy.经皮肾活检的并发症。
Adv Chronic Kidney Dis. 2012 May;19(3):179-87. doi: 10.1053/j.ackd.2012.04.003.
10
Bleeding complications of native kidney biopsy: a systematic review and meta-analysis.肾活检后出血并发症:系统评价和荟萃分析。
Am J Kidney Dis. 2012 Jul;60(1):62-73. doi: 10.1053/j.ajkd.2012.02.330. Epub 2012 Apr 24.